CAH Q1 FY2027 Revenue Rises 5% to $67.5B, Non-GAAP EPS Guidance Raised to $12.80–$13.00
· The NYC Memo
Cardinal Health reported Q1 fiscal year 2027 results for the quarter ended September 30, 2026, with revenue up 5% year-over-year to $67.5 billion and GAAP diluted EPS up 27% to $2.38. Non-GAAP diluted EPS rose 28% to $3.26, with GAAP operating earnings increasing 13% to $753 million and non-GAAP operating earnings increasing 17% to $1.0 billion.
The company raised its fiscal year 2027 non-GAAP diluted EPS guidance to $12.80–$13.00, up from the prior range of $12.40–$12.60, and disclosed a binding letter of intent to renew pharmaceutical distribution agreements with CVS Health.